## **Core Concept**
Sulphonamides are a class of antimicrobials that work by inhibiting folic acid synthesis in bacteria. They are often conjugated with other compounds to enhance their therapeutic efficacy or reduce side effects. The conjugation process involves the attachment of sulphonamide to another molecule, which can affect its pharmacokinetics and pharmacodynamics.

## **Why the Correct Answer is Right**
The correct answer, **. Para-Aminobenzoic Acid (PABA)**, is related to the mechanism of action of sulphonamides. Sulphonamides are structural analogues of PABA, which is a substrate for the enzyme dihydropteroate synthetase. This enzyme is crucial for the synthesis of dihydrofolic acid, a precursor to folic acid in bacteria. By conjugating with PABA, sulphonamides competitively inhibit dihydropteroate synthetase, thereby inhibiting bacterial folic acid synthesis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although acetylation is a metabolic modification that some drugs undergo, it is not the compound with which sulphonamide is conjugated in this context.
- **Option B:** This option is incorrect as there is no commonly known compound or relevance in the context of sulphonamide action or metabolism that matches this description.
- **Option D:** This option is incorrect because, while sulphonamides can be part of more complex drug molecules, the specific conjugation with this compound is not accurate in the context provided.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that sulphonamides can cause hypersensitivity reactions and are contraindicated in patients with known hypersensitivity to sulphonamides. Additionally, they are often used in combination with trimethoprim (co-trimoxazole), which acts synergistically by inhibiting dihydrofolate reductase, another enzyme in the folic acid synthesis pathway.

## **Correct Answer:** . Para-Aminobenzoic Acid (PABA)